The Future of
Medical AI
Delivered Weekly
Curated research insights for clinicians and patients. No hype. Just evidence.
Pathogenic germline variants identify elevated cancer risk in pediatric patients referred for genetic testing
Identifying inherited genetic risk variants in children helps doctors predict future tumor risks, enabling personalized counseling and early cancer surveillance starting today.
Why Medical Professionals Choose Mednosis
We cut through the noise to deliver research that actually matters
Built for Clinicians
Technical notes include study design, sample sizes, confidence intervals, and key limitations
Patient-Friendly
Every article includes plain language explanations your patients can understand
Zero Hype Guarantee
Practice impact ratings tell you exactly how close research is to clinical reality
Latest Research
Fibroblast growth factor receptor inhibition for succinate dehydrogenase-deficient gastrointestinal stromal tumors: a phase 2 trial
MAGE-A4/MAGE-A8-targeted TCR-based bispecific T cell engager in recurrent and/or refractory solid tumors: a phase 1 trial
Rehumanizing global health care with agentic AI
Get smarter about medical AI every week
Join clinicians and researchers staying ahead of the curve
Trending This Week
Research getting the most attention
Fibroblast growth factor receptor inhibition for succinate dehydrogenase-deficient gastrointestinal stromal tumors: a phase 2 trial
Coalition for Health AI unveils governance playbooks for responsible AI adoption - Fierce Healthcare
MAGE-A4/MAGE-A8-targeted TCR-based bispecific T cell engager in recurrent and/or refractory solid tumors: a phase 1 trial
Find What Matters to You
Filter research by how close it is to clinical practice
Browse by Specialty
Find research relevant to your field
Never Miss a
Breakthrough
Get curated AI in medicine research delivered weekly. No spam, unsubscribe anytime.
AI in Medicine 101
Learn how to read medical AI research, spot red flags in hype-y articles, and ask the right questions about new technologies.